Non-pharmaceutical measures to avoid individual contagion by SARS-Cov-2
Keywords:
SARS-CoV-2, covid-19, Peru, omicronAbstract
The purpose of this essay is to compile in an orderly manner various investigations regarding contagion by SARS-Cov-2, the omicron variant and sub-variants BA.4 - BA.5; as well as non-pharmaceutical measures that can be applied individually to avoid the severity of the disease.
Downloads
References
Peña RJC. ¿Cuáles son los riesgos de dispersión del COVID-19 en México?. Acta Med. 2021;19(1):151-156. doi:10.35366/98594.
Guallar María Pilar, Meiriño Rosa, DonatVargas Carolina, Corral Octavio, Jouvé Nicolás, Soriano Vicente, Inoculum at the time of SARSCoV-2 exposure and risk of disease severity, International Journal of Infectious Diseases, Volume 97, 2020, Pages 290-292, ISSN 1201- 9712, https://doi.org/10.1016/j.ijid.2020.06.035.
Concentración del material particulado PM2.5 en Lima Metropolitana, 2014-2019 (ug/ m3), 2014-2019 (ug/m3), Instituto Nacional sobre el Estado del Ambiente -INEA-, https://sinia.minam.gob.pe/inea/indicadores/concentracion-del-material-particulado-pm2-5-en-lima-metropolitana-2014-2019-ug-m3/
Aparco Juan Pablo, Fuentes Duilio, Gonzales Elena, Mormontoy Henry, Chirinos Katherine, Huaman Lucio, Palomino Miryam, Escalante Oscar, Hinojosa Paul, Angulo Yolanda “Presencia del SARS-CoV-2 en superficies de alimentos y otras superficies de espacios públicos en distritos de Lima Metropolitana”, 2020-2021.
Carlos del Rio, Preeti N. Malani, COVID-19 in 2022—The Beginning of the End or the End of the Beginning?, JAMA May 27 2022, doi:10.1001/ jama.2022.9655
Guillermo López Lluch, Covid: por qué están comparando a la variante ómicron del coronavirus con el sarampión, BBC Londres, https://www.bbc.com/mundo/noticias-59741569
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Mg. Víctor Vargas Fierro
This work is licensed under a Creative Commons Attribution 4.0 International License.
